Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine. It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B. A branded formulation, Comvax, was marketed in the US by Merck. It was discontinued in 2014.
Property | Value |
---|---|
dbo:abstract |
|
dbo:alternativeName |
|
dbo:casNumber |
|
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink | |
dbp:atcPrefix |
|
dbp:atcSuffix |
|
dbp:casNumber |
|
dbp:chemspiderid |
|
dbp:class | |
dbp:component |
|
dbp:routesOfAdministration | |
dbp:tradename |
|
dbp:type |
|
dbp:wikiPageUsesTemplate | |
dct:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageRedirects of | |
is dbo:wikiPageWikiLink of | |
is foaf:primaryTopic of |